免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Diagnostic Value of MRI for Allergic Broncho-Pulmonary Aspergilloses

NCT:NCT03265366 · COMPLETED

NCT IDNCT03265366
狀態COMPLETED
開始日期2017-09-14
完成時間2020-01-24
SponsorUniversity Hospital, Bordeaux (OTHER)
First posted
Last updated

簡要摘要

The aim of the study is to compare the concordance between chest computerized tomography-scan (CTscan) and Magnetic resonance Imaging (MRI) for the description of the abnormalities seen in Allergic BronchoPulmonary Aspergillosis (ABPA).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑